The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.

Target has growth opportunities, particularly in its digital sales business, and boasts an impressive dividend profile.

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new ...

Rockland Trust Co. has cut its Bristol-Myers Squibb stake by 10.3%, shedding 20,035 shares, now holding a still-mighty $10.7 ...

Biogen has emerged as a potential frontrunner at the Cannes Lions International Festival of Creativity, snagging four spots ...

A review of financial information, stocks, the economy, and all things finance to guide investment decisions.

Bristol-Myers Squibb ($BMY), a pharmaceutical giant, is trading at $49.73, far below its intrinsic value of $146.45, as calculated using the Buffett and ...

Sotyktu’s safety profile through 16 weeks of treatment remained consistent with previous reports throughout its clinical ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer ...

Artificial intelligence (AI) is playing a disruptive role across several industries as the technology allows businesses, governments, and organizations to improve productivity and efficiency with its ...

BARCELONA -- The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic ...